GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anavex Life Sciences Corp (STU:12X1) » Definitions » Beginning Cash Position

Anavex Life Sciences (STU:12X1) Beginning Cash Position : €111.72 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Anavex Life Sciences Beginning Cash Position?

Anavex Life Sciences's Beginning Cash Position for the quarter that ended in Mar. 2025 was €111.72 Mil.

Anavex Life Sciences's quarterly Beginning Cash Position increased from Sep. 2024 (€125.02 Mil) to Dec. 2024 (€126.24 Mil) but then declined from Dec. 2024 (€126.24 Mil) to Mar. 2025 (€111.72 Mil).

Anavex Life Sciences's annual Beginning Cash Position declined from Sep. 2022 (€153.63 Mil) to Sep. 2023 (€139.76 Mil) and declined from Sep. 2023 (€139.76 Mil) to Sep. 2024 (€136.07 Mil).

Anavex Life Sciences Beginning Cash Position Historical Data

The historical data trend for Anavex Life Sciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anavex Life Sciences Beginning Cash Position Chart

Anavex Life Sciences Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.84 24.86 153.63 139.76 136.07

Anavex Life Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.26 129.49 125.02 126.24 111.72

Anavex Life Sciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Anavex Life Sciences Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Anavex Life Sciences's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Anavex Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anavex Life Sciences Corp (STU:12X1) » Definitions » Beginning Cash Position
Comparable Companies
REPL TRVI DAWN VIR IMTX ABUS RCKT ANAB IOVA GHRS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
AVXL:USA 0HFR:UK 12X1:Germany
Address
630 5th Avenue, 20th Floor, New York, NY, USA, 10111
Website
https://www.anavex.com
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Anavex Life Sciences Headlines

No Headlines